Literature DB >> 24684205

Systems biology and proteomic analysis of cerebral cavernous malformation.

Alexander R Edelmann1, Sarah Schwartz-Baxter, Christopher F Dibble, Warren C Byrd, Jim Carlson, Ivandario Saldarriaga, Sompop Bencharit.   

Abstract

UNLABELLED: Cerebral cavernous malformations (CCM) are vascular anomalies caused by mutations in genes encoding KRIT1, OSM and PDCD10 proteins causing hemorrhagic stroke. We examine proteomic change of loss of CCM gene expression. Using human umbilical vein endothelial cells, label-free differential protein expression analysis with multidimensional liquid chromatography/tandem mass spectrometry was applied to three CCM protein knockdown cell lines and two control cell lines: ProteomeXchange identifier PXD000362. Principle component and cluster analyses were used to examine the differentially expressed proteins associated with CCM. The results from the five cell lines revealed 290 and 192 differentially expressed proteins (p < 0.005 and p < 0.001, respectively). Most commonly affected proteins were cytoskeleton-associated proteins, in particular myosin-9. Canonical genetic pathway analysis suggests that CCM may be a result of defective cell-cell interaction through dysregulation of cytoskeletal associated proteins.
CONCLUSION: The work explores signaling pathways that may elucidate early detection and novel therapy for CCM.

Entities:  

Keywords:  cerebral cavernous malformation; cytoskeletal proteins; mass spectrometry; proteomics; signaling; systems biology

Mesh:

Substances:

Year:  2014        PMID: 24684205      PMCID: PMC4066995          DOI: 10.1586/14789450.2014.896742

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  43 in total

Review 1.  The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications.

Authors:  Elisabetta Dejana; Elisabeth Tournier-Lasserve; Brant M Weinstein
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

2.  Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.

Authors:  Judith Gault; Issam A Awad; Peter Recksiek; Robert Shenkar; Robert Breeze; Michael Handler; Bette K Kleinschmidt-DeMasters
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

3.  Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells.

Authors:  Lisa E S Crose; Thomas L Hilder; Noah Sciaky; Gary L Johnson
Journal:  J Biol Chem       Date:  2009-03-24       Impact factor: 5.157

Review 4.  Transgelin: an actin-binding protein and tumour suppressor.

Authors:  Stephen J Assinder; Jo-Ann L Stanton; Priya D Prasad
Journal:  Int J Biochem Cell Biol       Date:  2008-03-10       Impact factor: 5.085

5.  Proteomic identification of the cerebral cavernous malformation signaling complex.

Authors:  Thomas L Hilder; Michael H Malone; Sompop Bencharit; John Colicelli; Timothy A Haystead; Gary L Johnson; Christine C Wu
Journal:  J Proteome Res       Date:  2007-09-27       Impact factor: 4.466

6.  Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition.

Authors:  Venkateshwar G Keshamouni; Pratik Jagtap; George Michailidis; John R Strahler; Rork Kuick; Ajaya Kumar Reka; Panagiotis Papoulias; Rashmi Krishnapuram; Anjaiah Srirangam; Theodore J Standiford; Philip C Andrews; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2009-01       Impact factor: 4.466

7.  Proteomic analysis of astroglial connexin43 silencing uncovers a cytoskeletal platform involved in process formation and migration.

Authors:  Stephan Olk; Andrey Turchinovich; Michael Grzendowski; Kai Stühler; Helmut E Meyer; Georg Zoidl; Rolf Dermietzel
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

8.  Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3.

Authors:  Leiling Chen; Gamze Tanriover; Hiroko Yano; Robert Friedlander; Angeliki Louvi; Murat Gunel
Journal:  Stroke       Date:  2009-02-26       Impact factor: 7.914

9.  KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions.

Authors:  Angela Glading; Jaewon Han; Rebecca A Stockton; Mark H Ginsberg
Journal:  J Cell Biol       Date:  2007-10-22       Impact factor: 10.539

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more
  3 in total

1.  Comparative omics of CCM signaling complex (CSC).

Authors:  Johnathan Abou-Fadel; Mark Smith; Kamran Falahati; Jun Zhang
Journal:  Chin Neurosurg J       Date:  2020-01-15

Review 2.  Introduction to cerebral cavernous malformation: a brief review.

Authors:  Jaehong Kim
Journal:  BMB Rep       Date:  2016-05       Impact factor: 4.778

3.  Systems-wide analysis unravels the new roles of CCM signal complex (CSC).

Authors:  Johnathan Abou-Fadel; Mariana Vasquez; Brian Grajeda; Cameron Ellis; Jun Zhang
Journal:  Heliyon       Date:  2019-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.